By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adamas Pharmaceuticals 

1900 Powell Street
Suite 1050
Emeryville  California  94608  U.S.A.
Phone: 510-450-3500 Fax: 510-428-0519


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Adamas Pharmaceuticals (ADMS) Completes Recruitment Of Its Phase III EASE LID Study Evaluating ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia Associated With Parkinson's Disease 7/10/2015 6:53:27 AM
Adamas Pharmaceuticals (ADMS) Issued U.S. Patent Relating To ADS-5102 Program 7/8/2015 7:16:47 AM
Adamas Pharmaceuticals (ADMS) To Present At The Cantor Fitzgerald InauguralHealthcare Conference 6/25/2015 12:04:59 PM
Adamas Pharmaceuticals (ADMS) Announces Additional Findings From Its Phase II/III Trial Of ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) Associated With Parkinson's Disease 6/15/2015 1:59:57 PM
Adamas Pharmaceuticals (ADMS) Begins Phase II Clinical Trial Assessing ADS-5102 For Treating Multiple Sclerosis Symptoms In Patients With Walking Impairment 6/12/2015 7:09:48 AM
Adamas Pharmaceuticals (ADMS) To Present At The 2015 JMP Securities Life Science Conference 6/10/2015 8:09:41 AM
Adamas Pharmaceuticals (ADMS) To Present At 2015 Needham Healthcare Conference 4/10/2015 8:43:37 AM
Adamas Pharmaceuticals (ADMS) Receives Orphan Drug Designation For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia Associated With Parkinson's Disease 4/10/2015 8:36:46 AM
Adamas Pharmaceuticals (ADMS) Issued Patent 3/31/2015 2:29:02 PM
Adamas Pharmaceuticals (ADMS) Reports Fiscal 2014 Financial Results 3/4/2015 7:33:08 AM
123456
//-->